Hallucinogen-persisting perception disorder (Q34037976)

30 July 2017

Hallucinogen-persisting perception disorder (English)

1 reference

hallucinogen persisting perception disorder

30 July 2017

0 references

author name string

Leo Hermle

1

1 reference

30 July 2017

Melanie Simon

2

1 reference

30 July 2017

Martin Ruchsow

3

1 reference

30 July 2017

Martin Geppert

4

1 reference

30 July 2017

1 October 2012

1 reference

Therapeutic advances in psychopharmacology

30 July 2017

1 reference

30 July 2017

2

1 reference

30 July 2017

5

1 reference

30 July 2017

199-205

1 reference

Hallucinogen persisting perception disorder after psilocybin consumption: a case study

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

5 July 2018

Hallucinogens: An update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

Hallucinogen persisting perception disorder: what do we know after 50 years?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

LSD-induced Hallucinogen Persisting Perception Disorder treated with clonazepam: two case reports

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

The psychopharmacology of hallucinogens

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

LSD-like panic from risperidone in post-LSD visual disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

Flashback phenomena. Clinical and diagnostic dilemmas.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

Flashbacks and memory phenomena. A comment on "Flashback phenomena - clinical and diagnostic dilemmas"

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

Visual Phenomenology of the LSD Flashback

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

5 July 2018

1 reference

https://api.crossref.org/works/10.1177%2F2045125312451270

Improvement of hallucinogen persisting perception disorder by treatment with a combination of fluoxetine and olanzapine: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2045125312451270

Chronic Administration of Serotonergic Antidepressants Attenuates the Subjective Effects of LSD in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2045125312451270

Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2045125312451270

Hallucinogen-induced psychological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2045125312451270

Flashbacks and Memory Phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2045125312451270

A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2045125312451270

LSD-induced Hallucinogen Persisting Perception Disorder with depressive features treated with reboxetine: case report.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

Risperidone-associated, benign transient visual disturbances in schizophrenic patients with a past history of LSD abuse.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

Lamotrigine in the treatment of depersonalization disorder.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3736944

A chronic impairment of colour vision in users of LSD

29 October 2018

1 reference

12 December 2020

Is there a role for the alpha2 antagonism in the exacerbation of hallucinogen-persisting perception disorder with risperidone?

1 reference

12 December 2020

Sertraline treatment of hallucinogen persisting perception disorder

1 reference

12 December 2020

Naltrexone treatment of hallucinogen persisting perception disorder

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1177/2045125312451270

1 reference

30 July 2017

1 reference

30 July 2017

1 reference